Home

RECOMBINANT PROTEINS
PREVIOUSLY OUT OF REACH

SCALABLE VIRAL VECTOR PRODUCTION

C1-INHIBITOR AND ALKALINE
PHOSPHATASE: GLYCO-OPTIMIZED
FOR THERAPEUTIC NEEDS

STABLE AAV PRODUCER CELL LINES

Meet us at

ASGCT 22nd ANNUAL MEETING

04/29/2019 – 05/02/2019
WASHINGTON, D.C., USA

 

Career

Open positions

Group Leader Upstream Process Development

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News,
including Press Releases, Conference Information and Webinar Invitations.

© Copyright – CEVEC 2019